Reply to: Comment on: Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma

Metadata

Item Type:	Article
Authors/Creators:	Brookes, M.J. Roundhill, E.A. https://orcid.org/0000-0002-0508-3648 Jeys, L. Parry, M. Burchill, S.A. https://orcid.org/0000-0002-1034-3723 Rankin, K.S.
Commentary on:	Brookes, MJ, Roundhill, EA, Jeys, L et al. (3 more authors) (2022) Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma. Pediatric Blood & Cancer, 69 (12). e29959. ISSN 1545-5009
Dates:	Published: May 2023 Published (online): 18 January 2023 Accepted: 21 December 2022
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Molecular Medicine
Depositing User:	Symplectic Publications
Date Deposited:	20 Nov 2024 12:10
Last Modified:	20 Nov 2024 12:13
Status:	Published
Publisher:	Wiley
Identification Number:	10.1002/pbc.30206
Related URLs:	Author
Sustainable Development Goals:
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:219866

Brookes, MJ, Roundhill, EA, Jeys, L, Parry, M, Burchill, SA and Rankin, KS Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma. (deposited 18 Nov 2022 12:52)
- Brookes, M.J., Roundhill, E.A., Jeys, L., Parry, M., Burchill, S.A. and Rankin, K.S. Reply to: Comment on: Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma. (deposited 20 Nov 2024 12:10) [Currently Displayed]

CORE (COnnecting REpositories)